Dr. Razavi joined the staff of St. Joseph Vascular Institute in August 2005 and currently serves as the Director of Clinical Trials and Research Center. Dr. Razavi specializes in image-guided therapy for cancer and endovascular treatment of vascular disease including carotid artery stent replacement. Before moving to Southern California, he was an Associate Professor of Interventional Radiology at the Stanford University Medical Center and the Director of the fellowship program. He had also served as the Acting Chief of Interventional Radiology at Stanford University Hospital.

Dr. Razavi received his medical degree from the University of Southern California and completed his Radiology residency training at UCLA, where he served as the Chief Resident. He has had two subspeciality fellowship trainings; first in Medical Imaging at UCLA, where his research concentrated on instrumentation and clinical evaluation of Picture Archiving and Communication Systems (PACS), and second in Cardiovascular Interventional Radiology at Stanford University Hospital. Dr. Razavi then joined the faculty of Interventional Radiology at UCLA and was the director of Special Procedures at the West Los Angeles VA Medical Center. In 1996, he went back to Stanford, where he was on the full-time faculty in the Vascular Center until 2005.

To date, he has authored and co-authored more than 250 scientific publications, abstracts, and book chapters and has been the recipient of many honors and awards from various professional medical societies. He has given over 120 invited lectures at national and international meetings and is considered an authority in the field of minimally invasive image-guided procedures.

Dr. Razavi is also the editor of Techniques in Vascular & Interventional Radiology and has served on the editorial board of other prestigious scientific journals. His scientific work has been featured in over 100 national and international radio, television and press news articles and programs. Dr. Razavi also serves on the Board of Directors and the Scientific Advisory Board of several device and biotechnology companies. He is a consultant to many medical device manufacturers and is co-founder of three medical device companies.

Telehealth